Evidence map›Paper›PMID 24244577›Full record

ArticlePloS one2013

ApoE production in human monocytes and its regulation by inflammatory cytokines.

Sten Braesch-Andersen, Staffan Paulie, Christian Smedman, Sohel Mia, Makiko Kumagai-Braesch

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Journal of inflammation research · 2026
    Article
  2. Review
  3. Article
  4. The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Anti-Inflammatory Effects of (3Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Cell-specific production, secretion, and function of apolipoprotein E.Journal of molecular medicine (Berlin, Germany) · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sten Braesch-AndersenMabtech, Nacka Strand, Sweden.
Staffan Paulie
Christian Smedman
Sohel Mia
Makiko Kumagai-Braesch
Mabtech (Sweden) · SEKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The apoE production by tissue macrophages is crucial for the prevention of atherosclerosis and the aim of this study was to further elucidate how this apolipoprotein is regulated by cytokines present during inflammation. Here we studied apoE production in peripheral blood mononuclear cells (PBMC) and analysis was made with a newly developed apoE ELISpot assay. In PBMC, apoE secretion was restricted to monocytes with classical (CD14(++)CD16(-)) and intermediate (CD14(+)CD16(+)) monocytes being the main producers. As earlier described for macrophages, production was strongly upregulated by TGF-β and downregulated by bacterial lipopolysaccharide (LPS) and the inflammatory cytokines IFN-γ, TNF-α and IL-1β. We could here show that a similar down-regulatory effect was also observed with the type I interferon, IFN-α, while IL-6, often regarded as one of the more prominent inflammatory cytokines, did not affect TGF-β-induced apoE production. The TNF-α inhibitor Enbrel could partly block the down-regulatory effect of IFN-γ, IFN-α and IL-1β, indicating that inhibition of apoE by these cytokines may be dependent on or synergize with TNF-α. Other cytokines tested, IL-2, IL-4, IL-12, IL-13, IL-17A and IL-23, had no inhibitory effect on apoE production. In contrast to the effect on monocytes, apoE production by primary hepatocytes and the hepatoma cell line HepG2 was more or less unaffected by treatment with cytokines or LPS.

Indexed as

Apolipoproteins EBiomarkersEtanerceptGene ExpressionGPI-Linked ProteinsHepatocytesHep G2 CellsHumansImmunoglobulin GImmunologic FactorsInterferon-gammaInterleukin-1betaInterleukin-6Lipopolysaccharide ReceptorsLipopolysaccharidesMonocytesApolipoproteins EBiomarkersEtanerceptFCGR3B protein, humanGPI-Linked ProteinsIL6 protein, humanImmunoglobulin GImmunologic FactorsInterferon-gammaInterleukin-1betaInterleukin-6Lipopolysaccharide ReceptorsLipopolysaccharidesReceptors, IgGReceptors, Tumor Necrosis FactorTransforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID24244577
PMCPMC3828220
OpenAlexW2077014061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.